Hu Lin, Bai Zhigang, Ma Xuemei, Bai Nan, Zhang Zhongtao
Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing, China.
Department of General Surgery, Beijing Jishuitan Hospital, The 4th Medical College of Peking University, Beijing, China.
J Gastric Cancer. 2020 Mar;20(1):95-105. doi: 10.5230/jgc.2020.20.e9. Epub 2020 Mar 20.
Gastric cancer is a highly metastatic malignant tumor, often characterized by chemoresistance and high mortality. In the present study, we aimed to investigate the role of B-cell lymphoma 3 (Bcl-3) protein on cell migration and chemosensitivity of gastric cancer.
The gastric cancer cell lines, AGS and NCI-N87, were used for the in vitro studies and the in vivo studies were performed using BALB/c nude mice. Western blotting, wound healing assay, Cell Counting Kit-8 assay, immunohistochemistry, and terminal deoxynucleotidyl transferase dUTP nick end labeling assay were used to evaluate the role of Bcl-3 in gastric cancer.
We found that the protein expression of hypoxia (HYP)-inducible factor-1α and Bcl-3 were markedly upregulated under hypoxic conditions in both AGS and NCI-N87 cells in a time-dependent manner. Interestingly, small interfering RNA-mediated knockdown of Bcl-3 expression affected the migration and chemosensitivity of the gastric cancer cells. AGS and NCI-N87 cells transfected with si-RNA-Bcl-3 (si-Bcl-3) showed significantly reduced migratory ability and increased chemosensitivity to oxaliplatin, 5-fluorouracil, and irinotecan. In addition, si-Bcl-3 restored the autophagy induced by HYP. Further, the protective role of si-Bcl-3 on the gastric cancer cells could be reversed by the autophagy inducer, rapamycin. Importantly, the in vivo xenograft tumor experiments showed similar results.
Our present study reveals that Bcl-3 knockdown inhibits cell migration and chemoresistance of gastric cancer cells through restoring HYP-induced autophagy.
胃癌是一种具有高度转移性的恶性肿瘤,常表现出化疗耐药性且死亡率高。在本研究中,我们旨在探究B细胞淋巴瘤3(Bcl-3)蛋白在胃癌细胞迁移和化疗敏感性中的作用。
采用胃癌细胞系AGS和NCI-N87进行体外研究,并使用BALB/c裸鼠进行体内研究。运用蛋白质免疫印迹法、伤口愈合试验、细胞计数试剂盒-8检测法、免疫组织化学法以及末端脱氧核苷酸转移酶dUTP缺口末端标记法来评估Bcl-3在胃癌中的作用。
我们发现,在缺氧条件下,AGS和NCI-N87细胞中缺氧诱导因子-1α(HYP)和Bcl-3的蛋白表达均呈时间依赖性显著上调。有趣的是,小干扰RNA介导的Bcl-3表达敲低影响了胃癌细胞的迁移和化疗敏感性。转染了si-RNA-Bcl-3(si-Bcl-3)的AGS和NCI-N87细胞显示出迁移能力显著降低,对奥沙利铂、5-氟尿嘧啶和伊立替康的化疗敏感性增加。此外,si-Bcl-3恢复了HYP诱导的自噬。进一步的研究表明,自噬诱导剂雷帕霉素可逆转si-Bcl-3对胃癌细胞的保护作用。重要的是,体内异种移植肿瘤实验也显示出类似的结果。
我们目前的研究表明,敲低Bcl-3可通过恢复HYP诱导的自噬来抑制胃癌细胞的迁移和化疗耐药性。